Advertisement
Screener

BIOMET INC Form 8-K: Current report, 2011

BIOMET INC Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2011-12-19: Form 8-K; Period of report 2011-12-19; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
  • 2011-12-09: Form 8-K; Period of report 2011-12-09; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
  • 2011-10-06: Form 8-K; Period of report 2011-10-06; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
  • 2011-07-28: Form 8-K; Period of report 2011-07-26; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
FiledFormPeriod of reportDescriptionDetailsDocument
2011-12-198-K2011-12-192.02 Results of Operations and Financial Condition2.02 On December 19, 2011, the Company issued a press release with respect to preliminary net sales results for the second fiscal quarter of fiscal 2012.d270788d8k.htm
2011-12-098-K2011-12-095.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 Effective December 9, 2011, Kevin J. Sierks, Vice President-Controller of LVB Acquisition, Inc. (the “Parent”) and Biomet, Inc. (the “Company”), resigned from his position to accept another career opportunity.d267466d8k.htm
2011-10-068-K2011-10-062.02 Results of Operations and Financial Condition2.02 On October 6, 2011, the Company issued a press release with respect to preliminary financial results for the first fiscal quarter of fiscal 2012.d240004d8k.htm
2011-07-288-K2011-07-265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On July 26, 2011, Stephen Ko resigned from the Board of Directors and from the Audit Committee of the Board of Directors of Biomet, Inc. (the “Company”).d8k.htm
2011-07-128-K2011-07-122.02 Results of Operations and Financial Condition2.02 On July 12, 2011, the Company issued a press release with respect to preliminary financial results for the fourth fiscal quarter of fiscal 2011 and for fiscal year 2011.d8k.htm
2011-04-128-K2011-04-122.02 Results of Operations and Financial Condition2.02 On April 12, 2011, the Company issued a press release with respect to results for the third fiscal quarter of fiscal 2011.d8k.htm
2011-02-158-K2011-02-105.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On February 10, 2011, the Board of Directors and stockholders of the Company’s parent company, LVB Acquisition, Inc. (“Parent”), adopted and approved the LVB Acquisition, Inc. Restricted Stock Unit Plan (the “Plan”).d8k.htm
2011-02-098-K2011-02-088.01 Other Events8.01 On February 8, 2011, Biomet, Inc. issued a press release reporting that the U.S. Food and Drug Administration (FDA) granted clearance of a 510(k) submission to market the Signature™ Personalized Patient Care System in the United States.d8k.htm
2011-01-068-K2010-12-312.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers2.02 On January 6, 2011, the Company issued a press release with respect to results for the second fiscal quarter of fiscal 2011.
5.02 (e) On December 31, 2010, the Board of Directors and stockholders of the Company’s parent company, LVB Acquisition, Inc. (“Parent”), approved and adopted Amendment No. 1 (the “Amendment”) to LVB Acquisition, Inc. Management Equity Incentive Plan (the “Plan”).
d8k.htm